Exelixis is an oncology-focused biotech company dedicated to innovating cancer treatments. The company operates under an ESG framework with four core themes: access to innovative and safe cancer medicines, community engagement and advocacy, people and culture, and environmental sustainability. Exelixis integrates ESG considerations directly into research and development projects and business operations.
About Exelixis
- Status
- Unverified
- Website
- Visit Website